Literature DB >> 25333209

A case-control study to assess the impact of mammographic density on breast cancer risk in women aged 40-49 at intermediate familial risk.

Valentina Assi1, Nathalie J Massat, Susan Thomas, James MacKay, Jane Warwick, Masako Kataoka, Iqbal Warsi, Adam Brentnall, Ruth Warren, Stephen W Duffy.   

Abstract

Mammographic density is a strong risk factor for breast cancer, but its potential application in risk management is not clear, partly due to uncertainties about its interaction with other breast cancer risk factors. We aimed to quantify the impact of mammographic density on breast cancer risk in women aged 40-49 at intermediate familial risk of breast cancer (average lifetime risk of 23%), in particular in premenopausal women, and to investigate its relationship with other breast cancer risk factors in this population. We present the results from a case-control study nested with the FH01 cohort study of 6,710 women mostly aged 40-49 at intermediate familial risk of breast cancer. One hundred and three cases of breast cancer were age-matched to one or two controls. Density was measured by semiautomated interactive thresholding. Absolute density, but not percent density, was a significant risk factor for breast cancer in this population after adjusting for area of nondense tissue (OR per 10 cm(2) = 1.07, 95% CI 1.00-1.15, p = 0.04). The effect was stronger in premenopausal women, who made up the majority of the study population. Absolute density remained a significant predictor of breast cancer risk after adjusting for age at menarche, age at first live birth, parity, past or present hormone replacement therapy, and the Tyrer-Cuzick 10-year relative risk estimate of breast cancer. Absolute density can improve breast cancer risk stratification and delineation of high-risk groups alongside the Tyrer-Cuzick 10-year relative risk estimate.
© 2014 UICC.

Entities:  

Keywords:  breast cancer; case-control; mammographic density; menopausal status

Mesh:

Year:  2014        PMID: 25333209     DOI: 10.1002/ijc.29275

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.

Authors:  Ya-Chen Tina Shih; Wenli Dong; Ying Xu; Ruth Etzioni; Yu Shen
Journal:  Ann Intern Med       Date:  2021-02-09       Impact factor: 25.391

Review 2.  Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene.

Authors:  Risa Kagan; Steven R Goldstein; James H Pickar; Barry S Komm
Journal:  Ther Clin Risk Manag       Date:  2016-04-07       Impact factor: 2.423

3.  Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors.

Authors:  Nick Perry; Sue Moss; Steve Dixon; Sue Milner; Kefah Mokbel; Charlotte Lemech; Hendrik-Tobias Arkenau; Stephen Duffy; Katja Pinker
Journal:  Diagnostics (Basel)       Date:  2020-06-20

4.  Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.

Authors:  Ana S Salazar; Malika Rakhmankulova; Laura E Simon; Adetunji T Toriola
Journal:  JNCI Cancer Spectr       Date:  2021-01-22

5.  The Relationship Between Mammographic Density and Factors Affecting Breast Cancer Risk.

Authors:  Havva Belma Kocer; Ebru Menekse; Umit Turan; Ozan Namdaroglu; Ayse Nurdan Barca; Levent Araz; Buket Altun Ozdemir; Betul Bozkurt
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-03-28

6.  Spatiotemporal Co-existence of Female Thyroid and Breast Cancers in Hangzhou, China.

Authors:  Xufeng Fei; George Christakos; Zhaohan Lou; Yanjun Ren; Qingmin Liu; Jiaping Wu
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

7.  Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer.

Authors:  Stephen W Duffy; Oliver W E Morrish; Prue C Allgood; Richard Black; Maureen G C Gillan; Paula Willsher; Julie Cooke; Karen A Duncan; Michael J Michell; Hilary M Dobson; Roberta Maroni; Yit Y Lim; Hema N Purushothaman; Tamara Suaris; Susan M Astley; Kenneth C Young; Lorraine Tucker; Fiona J Gilbert
Journal:  Eur J Cancer       Date:  2017-11-27       Impact factor: 9.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.